Lotus Bio-Technology Development Corp
Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lot… Read more
Market Cap & Net Worth: Lotus Bio-Technology Development Corp (LBTD)
Lotus Bio-Technology Development Corp (PINK:LBTD) has a market capitalization of $8.06 Million ($8.06 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #33629 globally and #10973 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lotus Bio-Technology Development Corp's stock price $0.01 by its total outstanding shares 806283694 (806.28 Million).
Lotus Bio-Technology Development Corp Market Cap History: 2015 to 2025
Lotus Bio-Technology Development Corp's market capitalization history from 2015 to 2025. Data shows change from $153.19 Million to $8.06 Million (-34.09% CAGR).
Lotus Bio-Technology Development Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lotus Bio-Technology Development Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LBTD by Market Capitalization
Companies near Lotus Bio-Technology Development Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Lotus Bio-Technology Development Corp by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
Lotus Bio-Technology Development Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Lotus Bio-Technology Development Corp's market cap moved from $153.19 Million to $ 8.06 Million, with a yearly change of -34.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.06 Million | 0.00% |
| 2024 | $8.06 Million | 0.00% |
| 2023 | $8.06 Million | -66.67% |
| 2022 | $24.19 Million | +275.00% |
| 2021 | $6.45 Million | +300.00% |
| 2020 | $1.61 Million | -13.04% |
| 2019 | $1.85 Million | +15.00% |
| 2018 | $1.61 Million | -90.00% |
| 2017 | $16.13 Million | -51.81% |
| 2016 | $33.46 Million | -78.16% |
| 2015 | $153.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Lotus Bio-Technology Development Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.06 Million USD |
| MoneyControl | $8.06 Million USD |
| MarketWatch | $8.06 Million USD |
| marketcap.company | $8.06 Million USD |
| Reuters | $8.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.